Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Arizona for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Arizona only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Arizona (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Mahmood El-gasim (NPI 1477814739)

Field	Value
Entity Type	Individual
Organization	Mahmood El-gasim
Address	4800 N 22nd St
City	Phoenix
State	AZ
ZIP	85016
Taxonomy	Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician
NPI Enumerated	June 4, 2012

Payer Source	Total Paid
Medicare	$3.7M
Medicaid	$0

Key Findings

This provider’s revenue is effectively single‑payer: Total Medicare revenue is $3.7M and there is no Medicaid billing on file (none below). The absence of Medicaid activity means contracting, utilization, and reimbursement exposure are concentrated on Medicare payment policies and beneficiary volume rather than a mixed payer footprint.

Revenue is highly concentrated in intravitreal injectable therapies: the precomputed top 3 Medicare codes account for 66.8% of this provider’s total Medicare revenue, led by J0178 ($1.2M, 32.7%), J2777 ($1M, 27.1%), and Q5124 ($258.4K, 7.0%). This concentration indicates the practice’s financial performance is closely tied to a small set of high‑value injectable drug codes.

The CPT/HCPCS mix points to a retina/uveitis service line focused on intravitreal drug administration and retinal imaging: high‑revenue drug codes (J0178, J2777, Q5124) and procedure code 67028 (2.7K claims, $255.9K revenue) show frequent intravitreal injections, while 92134 (3.6K claims, $101.3K revenue) and fluorescein angiography codes (92235, 92242) indicate substantial diagnostic retinal imaging supporting those injections. Together these codes are consistent with an ophthalmology practice delivering repeat injection therapy and longitudinal retinal monitoring.

On competitive standing the top drug codes are above median but not uniquely dominant: J0178 ranks #671 of 3204 providers (79th percentile; typical, unremarkable volume for this code), J2777 ranks #227 of 2039 providers (89th percentile; typical, unremarkable volume for this code), and Q5124 ranks #20 of 122 providers (84th percentile; typical, unremarkable volume for this code). In other words, the provider is a meaningful national participant in anti‑VEGF/faricimab administrations but not an outlier among peers for those specific drugs.

The practice shows pronounced above‑typical activity on several non‑drug procedure and billing lines: 92134 is an extreme outlier (3.6K claims, $101.3K revenue; 99th percentile) and 67028 appears notably above typical national volume (2.7K claims, $255.9K revenue; 97th percentile). High percentile placements for J7999 (1.2K claims, $86.5K revenue; 98th percentile) and 99214 (932 claims, $82.9K revenue; 97th percentile) further indicate elevated use of compounded/unclassified drug billing and higher‑level established patient E/M in comparison to peers. These patterns signal heavier procedural throughput and diagnostic imaging intensity than most national providers.

The drug coding mix includes branded biologics, biosimilars, and unclassified/compounded codes, which shapes per‑claim revenue: J3490 shows 93 claims with a $1768 avg paid/claim ($164.4K revenue), Q5128 and Q5124 together represent substantial biosimilar paid amounts ($145.9K and $258.4K respectively), and J7999 reports 1.2K claims ($86.5K revenue). This combination of high‑cost unclassified/drug codes plus biosimilars means changes in drug selection or reimbursement for these specific HCPCS codes would materially affect the provider’s Medicare revenue mix.

Provider tenure is well established: NPI enumerated on 2012-06-04 (~14 years ago), indicating a long‑running practice presence in the Phoenix market. That duration, combined with elevated volumes in imaging and procedure codes, suggests an entrenched referral and follow‑up workflow oriented around recurring retinal care.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

21 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,740	$690	$1.2M
J2777	Injection, faricimab‑svoa, 0.1 mg	34,500	$30	$1M
Q5124	Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg	1,520	$170	$258.4K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,670	$100	$255.9K
J3490	Unclassified drugs	90	$1,770	$164.4K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	690	$210	$145.9K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	1,100	$120	$130.3K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,620	$30	$101.3K
J2778	Injection, ranibizumab, 0.1 mg	540	$180	$96.7K
J7999	Compounded drug, not otherwise classified	1,220	$70	$86.5K

Showing 1–10 of 21

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 21 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Arizona Distribution

Mahmood El-gasim — 3 of 21 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Arizona

Full comparison — all codes billed, vs. state median

21 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	11	50	780	$690	$734.8K
J2777	9	50	9,000	$30	$525.8K
Q5124	3	10	1,250	$170	$209.2K
Q5128	8	20	520	$220	$207.5K
J2778	15	30	550	$180	$198K
67028	6	60	1,240	$90	$119K
J2781	3	10	650	$120	$92.4K
J7999	8	50	490	$70	$46.8K
67210	5	10	50	$390	$33.9K
92242	5	10	40	$200	$23.5K

Showing 1–10 of 21

Related Providers

Other providers that share a Tax Identification Number (TIN) with Mahmood El-gasim, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Barnet Dulaney Perkins Eye Center, PC	AZ	Ophthalmology Physician	$0	$10.9M
Sujit Itty	AZ	Ophthalmology Physician	$6.2M	$11.3K
Retinal Consultants Of Arizona Ltd	AZ	Ophthalmology Physician	$0	$6.2M
David Goldenberg	AZ	Retina Specialist (Ophthalmology) Physician	$4.7M	$15.8K
Neal Palejwala	AZ	Ophthalmology Physician	$4.4M	$2.9K
Sachin Mehta	AZ	Retina Specialist (Ophthalmology) Physician	$4.4M	$11.8K
Ronald Hobbs	AZ	Ophthalmology Physician	$4.1M	$0
Barnet Dulaney Perkins Eye Center, PC	AZ	Ambulatory Surgical Clinic/Center	$2.8M	$1.1M
Brendan Girschek	AZ	Ophthalmology Physician	$3.2M	$0
Karim Jamal	AZ	Ophthalmology Physician	$3.1M	$7.7K

Nearby Providers

Other providers in the same ZIP code as Mahmood El-gasim, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Phoenix Children's Hospital	AZ	Children's Hospital	$0	$555.8M
Instant Care Of Arizona	AZ	Home Health Agency	$0	$230.5M
Phoenix Children's Hospital	AZ	Pediatrics Physician	$0	$162.4M
Bethany Ranch Home, Inc	AZ	Intellectual Disabilities Intermediate Care Facility	$0	$74.4M
Creative Innervisions LLC	AZ	Intellectual and/or Developmental Disabilities Residential Treatment Facility	$0	$29.7M
Stellar Home Health, LLC	AZ	In Home Supportive Care Agency	$0	$29.4M
Crossroads, Inc	AZ	Substance Abuse Rehabilitation Facility	$0	$23.9M
Thomas Road Senior Housing, Inc.	AZ	Assisted Living Facility	$0	$19.2M
Anod Care Services,inc	AZ	Behavior Analyst	$0	$14.2M
National Council On Alcoholism Greater Phoenix Area	AZ	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$13.5M

Mahmood El-gasim — Billing Profile & Reimbursement Data

Sign up for Mahmood El-gasim — Billing Profile & Reimbursement Data policy alerts

Mahmood El-gasim — Billing Profile & Reimbursement Data

Sign up for Mahmood El-gasim — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References